HEALTHCARE M&A AND VALUATION
NEWS & INSIGHTS

Jan 221 min read

Scope Research's Healthcare M&A Review 2023

The Scope Research Healthcare M&A Review 2023 includes publicly announced healthcare M&A deal volume trends from 2019 through 2023, with...

Jan 192 min read

Radiation Therapy EBITDA Multiples: GenesisCare USA Sells Two Centers to U.S. Oncology (~2.7x EBITDA)

GenesisCare USA, the business formerly known as 21st Century Oncology, currently a subsidiary of KKR-backed, Australia-based GenesisCare,...

Jan 122 min read

PBM EBITDA Multiples: RiteAid Divests PBM Elixir for $575m (~6.1x EBITDA)

In a saga mirroring the turbulent fortunes of the brick-and-mortar pharmacy and PBM industries, Rite Aid swallowed a bitter pill on...

Jan 102 min read

Podiatry M&A and Valuation: Majority Stake in Beyond Podiatry Sold at $87 Million Valuation (~2.6x revenue)

Albaron Partners, a middle market private equity firm, announced that it has sold Beyond Podiatry to CUC Inc., a publicly-traded Japanese...